Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
human placenta-derived 3d mesenchymal stem cells
- Development stage
- Phase 2
- Lead developer
- Chinese PLA General Hospital
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intravenous
01
Overview
Human placenta-derived 3D mesenchymal stem cells (3D MSCs) is an investigational cell therapy developed by the Chinese PLA General Hospital for the treatment of acute ischemic stroke. Unlike traditional 2D-cultured MSCs, these cells are grown in a three-dimensional environment, which is intended to better mimic the physiological niche and enhance therapeutic properties such as paracrine secretion and survival. Administered intravenously, the therapy aims to mitigate brain injury by suppressing microglial activation and reducing neuroinflammation. It is currently being evaluated in Phase I/IIa clinical trials to assess safety and preliminary efficacy in the acute phase of stroke.
- Other names
- human placental-derived 3D mesenchymal stem cell injection3D-cultured human placenta-derived mesenchymal stem cells
Beyond the preview
Go deeper on human placenta-derived 3d mesenchymal stem cells.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on human placenta-derived 3d mesenchymal stem cells.